See All Slides - tctmd.com

Slides

Presentation TCT 2012

ABSORB (Abbott Vascular) Clinical Program to Date (and EXTEND Results): Strengths, Limitations, Including the 6-month Unknowns of the ABSORB Stent

Presenter: Antonio Bartorelli

October 23, 2012

Presentation TCT 2012

Pro: Femoral!

Presenter: Paul Teirstein

October 23, 2012

Presentation TCT 2012

ELM Presentation(7)

Presenter: Duane Pinto

October 23, 2012

Presentation TCT 2012

State of the Field Keynote: Impact of Emerging Biomaterials on Next-Generation Bioabsorbable Vascular Scaffold Development

Presenter: Syed Hossainy

October 23, 2012

Presentation TCT 2012

TCT-79. Chronic Total Occlusions in Sweden – Report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

Presenter: Truls R?munddal

October 23, 2012

Presentation TCT 2012

The Amaranth Stent: Design and Future Directions

Presenter: Juan Granada

October 23, 2012

Presentation TCT 2012

Introduction(3)

Presenter: Sunil Rao

October 23, 2012

Presentation TCT 2012

Thoratec Percutaneous Heart Pump

Presenter: Juan Granada

October 23, 2012

Presentation TCT 2012

The MitraClip Has an Important Role to Play!

Presenter: Ted Feldman

October 23, 2012

Presentation TCT 2012

TCT-45. Long Term Safety and Effectiveness of XIENCE V® Everolimus Eluting Coronary Stent System in Real-world Population: Three-Year Clinical Outcomes from the XIENCE V® USA Study

Presenter: James Hermiller Jr

October 23, 2012

Advertisement

Slides

ABSORB (Abbott Vascular) Clinical Program to Date (and EXTEND Results): Strengths, Limitations, Including the 6-month Unknowns of the ABSORB Stent

Pro: Femoral!

ELM Presentation(7)

State of the Field Keynote: Impact of Emerging Biomaterials on Next-Generation Bioabsorbable Vascular Scaffold Development

TCT-79. Chronic Total Occlusions in Sweden – Report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

The Amaranth Stent: Design and Future Directions

Introduction(3)

Thoratec Percutaneous Heart Pump

The MitraClip Has an Important Role to Play!

TCT-45. Long Term Safety and Effectiveness of XIENCE V® Everolimus Eluting Coronary Stent System in Real-world Population: Three-Year Clinical Outcomes from the XIENCE V® USA Study

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content